The 20 Best Hereditary Neuroblastoma Doctors in The United States

Yael Mosse is a Hematologist and an Oncologist practicing medicine in Philadelphia, Pennsylvania. Dr. Mosse is rated as an Elite provider by MediFind in the treatment of Hereditary Neuroblastoma. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Hereditary Neuroblastoma, and Rhabdomyosarcoma.

Thomas Russell is a Hematologist and a Pediatrics provider practicing medicine in Charlotte, North Carolina. Dr. Russell is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. His clinical expertise encompasses Neuroblastoma, Burkitt Lymphoma, Acute Lymphoblastic Leukemia (ALL), Leukemia, and Bone Marrow Aspiration. Dr. Russell is board certified in American Board Of Pediatrics, Pediatric Hematology And Oncology and American Board Of Pediatrics. Dr. Russell is currently accepting new patients.

Erin Trovillion is a Hematologist and a Pediatrics provider practicing medicine in Charlotte, North Carolina. Dr. Trovillion is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Ewing Sarcoma, Neuroblastoma, Osteosarcoma, and Chronic Graft Versus Host Disease (cGvHD). Dr. Trovillion is board certified in American Board Of Pediatrics and American Board Of Pediatrics, Pediatric Hematology And Oncology. Dr. Trovillion is currently accepting new patients.

. Dr. Popescu is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Hereditary Spherocytosis, Von Willebrand Disease (VWD), Evans Syndrome, and Hemophilic Arthropathy. Dr. Popescu is board certified in American Board Of Pediatrics.

Dr. Stanciu was born and raised in Bucharest, Romania, where she earned her Doctor of Medicine from Carol Davila University. She continued her medical training with an internship in general surgery and a general medicine residency in Bucharest, Romania. Dr. Stanciu moved to the United States in 1997 to complete an Internal Medicine Residency at Cook County Hospital in Chicago. She then completed an Endocrinology Fellowship at Loyola University in Maywood, Illinois.Dr. Stanciu is board-certified in endocrinology, diabetes, and metabolism, and internal medicine. She has expertise in parathyroid, osteoporosis, and other metabolic bone disorders (including rare bone disorders).Dr. Stanciu believes in engaging patients in learning about their disease and available treatment options to achieve the best possible outcomes. She aims to make patients comfortable with their treatment decisions, knowledgeable about the disease process, and encourage them to actively participate in their healing by promoting a healthy and active lifestyle.“I am thorough in my evaluation so I can understand the root cause of the disease, find the appropriate treatment option, and explain to the patient in easy-to-understand language. I love to see the patient getting back to an active lifestyle.”When she is not working, Dr. Stanciu enjoys the beautiful weather and mountains of Colorado, where she can be found hiking and camping in the summer and skiing in the winter. She has two daughters, one granddaughter, and three grandsons.Dr. Stanciu is a 5280 Magazine Top Doctor for 2020, 2021, 2023, and 2024. Dr. Stanciu is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Osteoporosis, Postmenopausal Osteoporosis, Hyperparathyroidism, and Neonatal Severe Hyperparathyroidism. Dr. Stanciu is board certified in American Board Of Radiology and American Board Of Internal Medicine. Dr. Stanciu is currently accepting new patients.

. Dr. Musgrave is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. She is also highly rated in 50 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Thrombocytopenia, Neuroendocrine Tumor, and Angiosarcoma. Dr. Musgrave is board certified in American Board Of Internal Medicine.

Pamela Kaiser is a Hematologist and an Oncologist practicing medicine in Park Ridge, Illinois. Dr. Kaiser is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Angiosarcoma, Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and Endoscopy. Dr. Kaiser is board certified in American Board Of Internal Medicine, Medical Oncology.

Daniel Shevrin, MD, a medical oncologist at Endeavor Health, combines advanced cancer knowledge with compassion and personalized care. He helps patients understand complex diagnoses and collaborates on treatment plans that balance effectiveness and quality of life. Dr. Shevrin is actively involved in prostate cancer research, leading a genomics study to guide more precise therapies for men with advanced disease. He sees each patient as a person first and believes empathy is as essential as evidence-based care. Dr. Shevrin is rated as a Distinguished provider by MediFind in the treatment of Hereditary Neuroblastoma. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Hereditary Neuroblastoma, Non-Muscle Invasive Bladder Cancer, and Prostatectomy. Dr. Shevrin is board certified in American Board Of Internal Medicine.

Dr. Szabo is board certified in hematology, medical oncology, and internal medicine. He completed his hematology-oncology training at Emory University Hospital and his internal medicine residency at the University of Michigan Hospitals. He earned his medical degree at Cornell University Medical College.Dr. Szabo has been practicing medicine for more than 20 years. Most recently, he was Chief of Staff at Emory St. Joseph Hospital. Prior to that, he was Chief of Staff at Emory Johns Creek Hospital and the Director of the Division of Community Oncology for the Department of Hematology Oncology at Emory Healthcare.Dr. Szabo has special interests in breast cancer, gastrointestinal cancer, and benign and malignant hematology. In his free time, Dr. Szabo enjoys promoting health education, hiking, sailing, and spending time with his family.Dr. Szabo and the team at Piedmont Oncology have the resources you need conveniently close to home.Dr. Szabo is accepting new patients and welcomes most major insurance plans. Dr. Szabo is rated as a Distinguished provider by MediFind in the treatment of Hereditary Neuroblastoma. He is also highly rated in 147 other conditions, according to our data. His clinical expertise encompasses Hereditary Neuroblastoma, Inflammatory Breast Cancer, Gastric Lymphoma, Bone Marrow Aspiration, and Colonoscopy. Dr. Szabo is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine - Hematology, and American Board Of Internal Medicine - Medical Oncology. Dr. Szabo is currently accepting new patients.

Anand Vaidya is an Endocrinologist practicing medicine in Boston, Massachusetts. Dr. Vaidya is rated as a Distinguished provider by MediFind in the treatment of Hereditary Neuroblastoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Glomus Tympanum Tumor, Hereditary Neuroblastoma, Neuroblastoma, and Glomus Jugulare Tumor. Dr. Vaidya is board certified in Endocrinology, Diabetes And Metabolism.

Gary D. Hammer, M.D., Ph.D. is Professor in Departments of InternalMedicine (MEND), Cell & Developmental Biology, and Molecular &Integrative Physiology. He currently serves as Director of EndocrineOncology Program in Rogel Cancer Center where he holds the MillieSchembechler Professorship in Adrenal Cancer. He is past Director ofCenter for Organogenesis: Stem Cells & Regenerative Medicine. He hasbrokered the recent renaissance of the current Michigan team of adrenalscientists that includes a who’s who in the study of adrenal disease.He received the UofM Jerome Conn Award for Outstanding Research inInternal Medicine, the Endocrine Society Edwin B. Astwood Award forOutstanding Research and is a member of ASCI and AAP. He has served innumerous leadership roles at UofM and in the public and private sectorsincluding recent tenure on Board of Scientific Advisors for NCI. He isthe editor of four textbooks including Pathophysiology of Disease: AnIntroduction to Clinical Medicine (McGraw Hilll), and the upcomingAdrenal Section Editor for Degroot’s Endocrinology (Elsevier). He hasserved in numerous capacities for the world’s largest endocrineorganization, the Endocrine Society including his most recent role asPresident of the Society (2020-2021). An Advisor to the CongressionalH.E.L.P. committee - he co-authored the 21st Century Cancer ALERT(Access to Life-Saving Early detection, Research and Treatment) Act’’ lintroduced in Congress in 2009. He has been catalyst for the formationof two international cooperative groups, most recently the A5 (AmericanAustralian Asian Adrenal Alliance) that leverages collaboration tosecure projects from Pharma and funding agencies across the spectrum ofadrenal diseases. He is a cofounder of two companies - MILLENDO andSLING THERAPEUTICS that focus on rare endocrine diseases. Dr. Hammer is rated as a Distinguished provider by MediFind in the treatment of Hereditary Neuroblastoma. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Adrenal Cancer, Adrenocortical Carcinoma, Neuroblastoma, and Hereditary Neuroblastoma. Dr. Hammer is board certified in Endocrinology, Diabetes & Metabolism.

Shannon T Kahn, M.D. earned her medical degree and completed her residency at Emory University School of Medicine. She is board certified in Radiation Oncology by the American Board of Radiology.Dr. Kahn specializes in breast, lung, gastrointestinal, central nervous system, genitourinary, thoracic, lymphomatous and skin cancers. She has a special interest in Stereotactic body and brain radiation therapy, high dose rate brachytherapy.In her spare time, Dr. Kahn enjoys playing tennis, the ocean, and traveling. Dr. Kahn is rated as a Distinguished provider by MediFind in the treatment of Hereditary Neuroblastoma. She is also highly rated in 30 other conditions, according to our data. Her clinical expertise encompasses Acoustic Neuroma, Hereditary Neuroblastoma, Schwannoma, Posterior Fossa Tumor, and Gamma Knife Radiosurgery. Dr. Kahn is board certified in American Board Of Radiology - Radiation Oncology. Dr. Kahn is currently accepting new patients.

. Dr. Emberesh is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Hereditary Spherocytosis, Evans Syndrome, Febrile Neutropenia, and Dyserythropoietic Anemia and Thrombocytopenia. Dr. Emberesh is board certified in American Board Of Pediatrics.

. Dr. Halligan is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Rhabdomyosarcoma, Neuroblastoma, and Ewing Sarcoma. Dr. Halligan is board certified in American Board Of Pediatrics.

. Dr. White is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Rosai-Dorfman Disease, Langerhans Cell Histiocytosis, and Non-Langerhans-Cell Histiocytosis. Dr. White is board certified in American Board Of Pediatrics.

. Dr. Manukian is rated as an Experienced provider by MediFind in the treatment of Hereditary Neuroblastoma. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Breast Cancer, and Pleuropulmonary Blastoma. Dr. Manukian is board certified in American Board Of Radiology.

Dr. Francis Worden received his medical degree from the Indiana University School of Medicine in 1993. Prior to attending medical school, he worked as a registered pharmacist at a large community hospital in Indianapolis. In 1997, Dr. Worden completed a combined residency in internal medicine and pediatrics at the Detroit Medical Center and finished a medical oncology/hematology fellowship at the University of Michigan. In July 2000, Dr. Worden joined the faculty at the University of Michigan Rogel Cancer Center, where he is currently working as a clinical investigator with both the multidisciplinary head and neck oncology team and the multidisciplinary lung cancer team. Dr. Worden's research interests include organ preservation in head and neck cancer and endocrine oncology. He is the Nancy Wigginton Oncology Research Professor of Thyroid Cancer. Avid competitive swimmer ; cyclist and runner. Dr. Worden is rated as a Distinguished provider by MediFind in the treatment of Hereditary Neuroblastoma. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Throat Cancer, Thyroid Cancer, and Head and Neck Squamous Cell Carcinoma (HNSCC). Dr. Worden is board certified in Medical Oncology.

Dr. Else’s primary appointment is with the Division of Metabolism, Endocrinology and Diabetes. He received his MD degree from the University of Hamburg, Germany. He pursued his clinical training at the University of Hamburg (Residency: Internal Medicine) and the University of Michigan (Residency: Internal Medicine, Fellowship: Endocrinology). His main research interests are the genetics of endocrine tumors. Dr. Else’s clinical practice focuses on the care for patients with benign and malignant endocrine tumors, particularly pheochromocytoma, adrenocortical tumors and neuroendocrine tumors as well as accompanying hormone excess syndromes (e.g Cushing syndrome, primary aldosteronism). Dr. Else has a particular interest in taking care of patients with hereditary syndromes that predispose to the development of endocrine tumors (e.g. Multiple Endocrine Neoplasia (MEN) type 1, MEN2A & MEN2B, Hereditary Paraganglioma Syndrome). He attends the Multidisciplinary Endocrine Oncology Clinic, where patients with tumors receive diagnostic procedures and treatment. In addition he is part of the Cancer Genetics Clinic, which evaluates patients for hereditary syndromes and also facilitates regular exams and surveillance for patients at risk for endocrine tumors. Dr. Else is rated as an Advanced provider by MediFind in the treatment of Hereditary Neuroblastoma. He is also highly rated in 105 other conditions, according to our data. His clinical expertise encompasses Adrenal Cancer, Adrenocortical Carcinoma, Adrenal Gland Adenoma, Neuroendocrine Tumor, and Thyroidectomy. Dr. Else is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Rafi Kabarriti, MD, is a cum laude graduate of Columbia University with a bachelor’s degree in biochemistry and economics. Dr. Kabarriti is rated as an Advanced provider by MediFind in the treatment of Hereditary Neuroblastoma. He is also highly rated in 54 other conditions, according to our data. His clinical expertise encompasses Anal Cancer, Laryngeal Cancer, Throat Cancer, Cervical Cancer, and Colonoscopy.

Diane Reidy is a Hematologist Oncology specialist and a Hematologist practicing medicine in Durham, North Carolina. Dr. Reidy is rated as an Advanced provider by MediFind in the treatment of Hereditary Neuroblastoma. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Pancreatic Cancer, Pancreaticoduodenectomy, and Liver Embolization.